New developments in mechanisms of obesity-induced hypertension: Role of adipose tissue
- 作者Arya M. Sharma; Stefan Engeli; Tobias Pischon
- 卷第3卷
- 期第2期
- 印刷ISSN1522-6417
- 电子ISSN1534-3111
- 文件大小266.50KB
- 发表时间2001
- DOI10.1007/s11906-001-0030-x
- 页码152-156
Spironolactone in the management of congestive heart failureJames E. Muller · 1990
Spironolactone in the Management of Congestive Heart FailureSteven R. Kayser · 2000
Spironolactone reduced mortality in severe congestive heart failureHenderson, M. · Evidence-Based Medicine · 2000
Spironolactone in the Treatment of Congestive Heart FailureLloyd, Stanley J; Mauro, Vincent F · The Annals of Pharmacotherapy · 2000
IS THE ADDITION OF SPIRONOLACTONE NECESSARY IN CONGESTIVE HEART FAILURE?Inpharma Weekly · 1977
Diuretic therapy in congestive heart failure – new aspects regarding spironolactone therapyHaller, · Therapeutische Umschau · 2000
Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactoneCruz, C. S. · Nephrology Dialysis Transplantation · 2003